All News

Epimacular brachytherapy does not reduce the number of ranibizumab injections required by patients with chronic, active neovascular age-related macular degeneration (ARMD), and it is associated with worse visual acuity compared with anti-vascular endothelial growth factor (VEGF) treatment alone, according to a study published in JAMA Ophthalmology.

The FDA has approved a new pooled method of testing individuals for coronavirus disease 2019 (COVID-19); early data show a drug developed by Synairgen yielded positive results in patients with COVID-19; some hospitals report shortages of young doctors, due in part to new visa restrictions enacted by the Trump administration.

By delivering helpful information and fostering online communities, social media may provide rehabilitation and psychological benefits for patients with multiple sclerosis (MS) who have depression, according to the results of a recent Iranian study.

Before coming to the clinic, they had been treated conservatively by primary care physicians and had suffered from pain anywhere from 2 to 40 years.

The company said FDA has set a date of January 20, 2021, for action under the Prescription Drug User Fee Act.

US cancer researchers benefit from the exchange of information with the World Health Organization (WHO), which helps domestic patients as well as international ones.

A recent review discussed how to manage comorbid cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD).

A new study suggests patients with multiple sclerosis (MS) will see their ability to walk decline more rapidly than their hand function.

Older patients with chronic lymphocytic leukemia (CLL) appear to be more likely to have severe symptoms if they contract coronavirus disease 2019, according to new research.

Only about one-third of patients with multiple myeloma who experience a very good partial response to therapy following first relapse, according to a new study.

Psoriatic arthritis and psoriasis have high economic burdens and the total annual costs were similar between the 2 diseases, but the combination of both yielded the highest costs, according to an abstract published at the European League Against Rheumatism annual meeting.

Even in individuals who don't have diabetes, hyperglycemia is an independent risk factor for COVID-19 mortality after 28 days of hospitalization, according to a study published in Diabetolgia.

A recent review explored the mechanism of a 5-hydroxytryptamine (5-HT 1f) agonist used in the treatment of acute migraine pain.

While minimal residual disease has become an important way to track how patients respond to therapies for multiple myeloma, the treatment implications of the metric are not yet clear, according to a review article.

A new analysis of nearly 3 decades of data suggests leukemia rates are falling, except for 2 specific types.

The designation would be to reduce the risk of heart failure or cardiovascular death in patients who have suffered an acute MI, which is a known cause of heart failure.

Patients with Parkinson disease who experience visual impairment were found to be more prone to behavioral issues such as depression and anxiety, as well as dementia and death, according to study findings.

Because male breast cancer is such a rare disease, few strides have been made that convey advantages in its detection, incidence, and mortality. Most treatment guidelines have been extracted from studies performed among female patients.

Hemophilia care principles have been on the rise in Europe over the course of the last decade, however, differing regions and policies on the continent reveal gaps in access to various treatments and specialty services.

Automatic positive airway pressure was found to significantly improve peak oxygen uptake, left ventricular function, and quality of life in patients with comorbid obstructive sleep apnea and heart failure with reduced left ventricular ejection fraction, according to study findings.

Using composite endpoints to predict clinically important deterioration in chronic obstructive pulmonary disease (COPD) could help investigators assess disease activity in clinical trials and better manage individual patients, according to a recent study.

American Diabetes Association–supported legislature to cap insulin costs passes in New Hampshire; cases of coronavirus disease 2019 (COVID-19) continue to shatter records; public health efforts to limit the spread of mosquito-borne illness take a back seat to the COVID-19 pandemic.

Karen Kobelski is the vice president and general manager of clinical surveillance, compliance & data solutions at Wolters Kluwer. She brings more than 25 years of experience to her position, which expands her previous leadership role over the Safety & Surveillance group to also include the Health Language portfolio of data normalization solutions.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Promoting engagement in physical activity in early rheumatoid arthritis (RA) can provide small benefits, according to results from a proof of concept study published in Musculoskeletal Care.

Transient ischemic attack is a common form of stroke, and 1 in 4 stroke survivors go on to experience a second stroke—most within the first month.

This week, the top managed care news included states facing COVID-19 spikes reporting health coverage losses; new COVID-19 data protocol raises concerns; and experts discuss key steps to reduce racial inequities in cancer care.

The review article highlights the many ways that multiple sclerosis (MS) affects women over the lifespan, from pregnancy to childbirth to menopause and beyond—and how both research and clinical practice fall short in meeting their needs.

Facedown positioning following surgery is not more likely to close large (≥400 mcm) macular holes compared with seating faced forward, according to a study published in JAMA Ophthalmology. However, visual acuity outcomes may be superior when patients are placed facedown after surgery.

Stress cardiomyopathy has presented in more patients with acute coronary syndrome during the coronavirus disease 2019 pandemic, despite none having positive antibody results for the virus, compared with several measured periods before the pandemic.